SAFAL has been designed in such a way that it will help schools, teachers, and policymakers understand how well students are ...

Company AnnouncementEPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for ...

Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...

Global Confirmatory Phase 3 DeLLphi-304 Trial Showed IMDELLTRA Reduced Risk of Death by 40% Compared to Chemotherapy Underscores IMDELLTRA as a Recognized Standard ...

Results from the metallurgical testwork program are expected in Q1 2026 (Figure 3).

After four years of systematic exploration in Mongolia, and with the help of BHP’s Xplor program in 2023, AZ9 has made what ...

Discover why Maple Gold Mines is a top investment in Québec’s Abitibi Belt, with strong funding, strategic partners, and ...

Rachna Sagar Pvt. Ltd, India's leading educational publishers. Since its inception, the organization has moved decisively ...

AI-enabled wearables are transforming preventive health by detecting abnormal heart rhythms, seizure-risk patterns and stress ...

Explore rising inflation, Fed rate cuts, and tight credit spreads. Discover why precious metals are soaring and how resource ...

A similar proportion of eighth-graders failed to come up with the following sum: 12 + (-4) + 12 + 4 = _______. By the 12th ...

That's the average no-show rate plaguing B2B SaaS companies right now. Even worse? When demos are scheduled more than 7 days out, that number jumps to a de ...